All benchmarks
Healthcare & Medical

General medical practice - R&D Tax Benchmark

What proportion of total business expenses do Australian general medical practice typically claim as R&D under the RDTI?

Typical range
0–3%
Direct (core) R&D as % of expenses
Elevated but plausible
up to 7%
Still defensible with strong evidence
Unusual - review carefully
> 12%
May still be valid; expect AusIndustry scrutiny
Supporting R&D
0–2%
Indirect / supporting activities

What drives R&D intensity in this sector

GP clinics rarely generate experimental work other than registered clinical trials or distinct software/process R&D arms.

Sector disclaimer

Day-to-day general practice is consultative care, not R&D. Higher allocations typically only appear where the clinic is running formal trials or developing a separate digital health / triage product.

ATO & AusIndustry context

ATO TR 2021/5 emphasises hypothesis-led experimentation. Diagnosis-and-treatment workflows are not core R&D activities.

Estimate your own RDTI offset

Plug your turnover, total expenses and notional R&D deductions into our free estimator and benchmark them against this sector range automatically.

Open the offset estimator

More benchmarks in Healthcare & Medical

Educational benchmark only - not an eligibility test or tax advice. Final eligibility depends on whether your activities meet the s.355-25 / s.355-30 core and supporting R&D definitions and is determined by AusIndustry on registration.